Patents/Assignees

OSE IMMUNOTHERAPEUTICS

12 patents in portfolio

US12534533utility2026
Anti-chemokine Like Receptor 1 Humanized Antibodies and Their Therapeutic Applications
0 cites
US12448454utility2025
Humanized Anti-clec-1a Antibodies and Antigen-binding Fragments Thereof
0 cites
US12371502utility2025
Antibodies Directed Against CD127
0 cites
US12331115utility2025
Uses of Anti-sirpg Antibodies
0 cites
US12331118utility2025
Humanized Anti-human-pd-1 Antibody and Methods of Using Them for Cancer Treatment
0 cites
US12252546utility2025
Anti-sirpa Antibodies and Their Therapeutic Applications
0 cites
US12091464utility2024
Method of Promoting a T-cell Response or Treating Cancer by Administering an Antagonist to Human C-type Lectin-like Receptor-1 (CLEC-1)
0 cites
US11981713utility2024
Method for Manufacturing a Stable Emulsion for Peptide Delivery
0 cites
US11926671utility2024
Antibodies and Polypeptides Directed Against CD127
0 cites
US11884723utility2024
Use of Anti-human Sirpa V1 Antibodies and Method for Producing Anti-sirpa V1 Antibodies
0 cites
US11713356utility2023
Modified Bifunctional Anti-human Signal Regulatory Protein Alpha (sirpa) Antibody and Method of Use Thereof for Treating Cancer
0 cites
US11696936utility2023
Treatment of Cancer
0 cites